C Balsano
Overview
Explore the profile of C Balsano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gori M, Barbaro B, Arciello M, Maggio R, Viscomi C, Longo A, et al.
J Cell Physiol
. 2015 Jul;
230(6):1400.
PMID: 26179116
No abstract available.
2.
Iannucci G, Scarpellini E, Balsano C, Paroli M, Leone G, Giannoni M
Eur Rev Med Pharmacol Sci
. 2014 Jun;
18(11):1680-1.
PMID: 24943983
No abstract available.
3.
Scarpellini E, Abenavoli L, Balsano C, Gabrielli M, Luzza F, Tack J
Eur Rev Med Pharmacol Sci
. 2014 Jan;
17 Suppl 2:39-44.
PMID: 24443067
Orocecal transit time (OCTT) is one of the main determinant of the hunger ratings and gastrointestinal sensitivity. While marked-isotopes scintigraphy is the gold standard in its determination in the clinical...
4.
Iannucci G, Balsano C, Paroli M, Scarpellini E, Leone G, Giannoni M
Eur Rev Med Pharmacol Sci
. 2013 Dec;
17(23):3164-8.
PMID: 24338457
Background And Aim: Blood pressure is an independent predictor of target organ damage (TOD). Recent data from literature suggest that TOD can be present also in pre-hypertensive subjects, diagnosed with...
5.
Balsano C
Mini Rev Med Chem
. 2008 May;
8(4):307-18.
PMID: 18473923
The management of HBV or HCV has improved dramatically over the last decade with the development of new drugs. This paper provides a review of new available and developing treatment...
6.
Alisi A, Balsano C
Nutr Rev
. 2008 Feb;
65(12 Pt 1):550-3.
PMID: 18236694
Hepatocellular carcinoma (HCC) is a common cancer worldwide. A majority of HCC patients present with an unresectable or metastatic HCC and systemic therapy with cytotoxic agents provides marginal benefits. Some...
7.
Alisi A, Spaziani A, Anticoli S, Ghidinelli M, Balsano C
Cell Signal
. 2008 Jan;
20(3):534-42.
PMID: 18164587
Myogenic differentiation is a highly orchestrated multistep process controlled by extracellular growth factors that modulate largely unknown signals into the cell affecting the muscle-transcription program. P38MAPK-dependent signalling, as well as...
8.
Alisi A, Giannini C, Spaziani A, Anticoli S, Caini P, Zignego A, et al.
Dig Liver Dis
. 2007 Dec;
39 Suppl 1:S72-5.
PMID: 17936228
HCV chronic infection leads to liver diseases and also to a wide range of extrahepatic disorders including benign, but pre-lymphomatous forms (mixed cryoglobulinemia) to frank hematological neoplasia (non-Hodgkin's lymphoma). Recent...
9.
Alisi A, Mele R, Spaziani A, Tavolaro S, Palescandolo E, Balsano C
J Cell Physiol
. 2005 May;
205(1):25-31.
PMID: 15880455
Hepatitis C virus (HCV) is the major causative viral agent of cirrhosis and hepatocarcinoma (HCC). HCV core protein affects cell homeostasis, playing an important role in viral pathogenesis of HCC....
10.
Artini M, Cariani E, Almerighi C, Fulco M, Rossini A, Pietropaolo L, et al.
Dig Liver Dis
. 2002 Dec;
34(8):570-6.
PMID: 12502213
Background: Infection with transfusion transmitted virus, a new member of the Parvoviridae family, has been found in patients both with chronic and fulminant post-transfusion cryptogenic hepatitis. Aim: To evaluate the...